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Background: Knowledge regarding the health-related quality of life (HRQoL) of children with celiac disease remains
limited and inconclusive. We investigated the HRQoL of three groups of 12-year-olds with: i) undetected celiac
disease ii) clinically diagnosed celiac disease, and iii) without celiac disease.
Methods: A school-based cross-sectional multicenter screening study invited 18 325 children, whereof 68% consented
to participate. Participants provided a blood sample, which was later analyzed for anti-tissue-tranglutaminase
antibodies, and alongside filled in a questionnaire. When anti-tissue-tranglutaminase antibodies were elevated, a
small intestinal biopsy verified the screening-detected celiac disease diagnosis. Self-reported HRQoL was measured
using Kidscreen, a generic 52 items instrument with proven reliability and validity. Scores were linearly transformed
into a 0–100 scale with higher values indicating better HRQoL. Mean values with standard deviations (mean ± SD)
were compared, and uni- and multivariate logistic regression models tested the odds of a low HRQoL among
children with undetected or diagnosed celiac disease, respectively.
Results: Children with undetected celiac disease (n = 238) reported similar HRQoL as children without celiac
disease (n = 12 037) (83.0 ± 11.0 vs. 82.5 ± 11.3, P = 0.51), and also similar HRQoL (82.2 ± 12.2, P = 0.28) to that of
children with diagnosed celiac disease (n = 90), of whom 92% were adherent to treatment. Having undetected
celiac disease did not increase the odds of low overall HRQoL, independent of sex, area of residence, study year
and occurrence of gastrointestinal symptoms (adjusted odds ratio 0.77, 95% CI 0.54-1.10). Comparable results were
seen for diagnosed celiac disease cases (adjusted odds ratio 1.11, 95% CI 0.67-1.85).
Conclusion: Children with undetected celiac disease reported comparable HRQoL as their peers with diagnosed
celiac disease, and those without celiac disease, when reporting prior to receiving the diagnosis through
screening. Thus, children with celiac disease, both untreated and diagnosed, perceive their HRQoL as unimpaired
by their disease.
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Celiac disease is one of the most common chronic dis-
eases in childhood, affecting around 1% of the popula-
tion [1]. In some genetically predisposed individuals,
dietary intake of gluten, found in wheat, ray, and barley,
results in an immune-mediated small intestinal enterop-
athy [1-3]. Although the classical symptoms are related
to the enteropathy (diarrhea, malnutrition, and failure to
thrive), it has become evident that celiac disease can de-
velop at any age with varying clinical presentations [4,5].
Especially when untreated, the disease has been associ-
ated with an increased risk of morbidity and mortality
[3,6,7]. Serological markers indicative of untreated disease
are in general use, but demonstration of small intestinal
enteropathy remains the gold standard for diagnosis [8].
With treatment, a strict gluten-free diet, the serological
markers normalize, the small intestinal mucosa recovers,
and symptoms alleviate [3,9]. However, adhering to a strict
gluten-free diet poses difficulties in everyday life including
increased costs, social restrictions and stigmatisation,
which may impact negatively on the health-related quality
of life (HRQoL) [10-14].
Screening studies have shown that the majority of chil-
dren with celiac disease are undiagnosed [4,15,16], and
mass screening might be an option for finding these
cases [17]. The high rate of under-diagnosis has been at-
tributed to the varying clinical presentation, where the
classical gastrointestinal symptoms most commonly are
either mild or lacking [9,18]. Children with undiagnosed
celiac disease do not experience enough symptoms to re-
ceive correct diagnosis; however, it remains poorly under-
stood whether these children are completely unaffected or
if undiagnosed celiac disease affects the HRQoL.
HRQoL assessments have become increasingly im-
portant in health care and research as it offers a more
comprehensive understanding of the disease impact for
the individual compared to that of laboratory analyses
and disease related symptoms alone [19]. HRQoL is de-
fined as a multidimensional construct encompassing
several areas of life; physical, emotional, mental, social
and behavioural components of functioning and wellbeing,
as perceived by the individual and/or others [20,21]. Several
HRQoL instruments have been developed during the last
decades, including a European cross-country instrument
called Kidscreen [21,22].
In previous studies among adults, undetected celiac
disease has been associated with reduced HRQoL, mostly
with a subsequent improvement after initiation of treat-
ment [14,23]. Such an improvement has also been seen
among screening-detected cases [24,25], although the
findings are inconsistent [14,23,24,26,27]. Most previous
studies of HRQoL and celiac disease have been performed
among adults and studies of HRQoL in children with ce-
liac disease are limited and inconclusive [23,28-31].In this study we investigated and compared the HRQoL
assessed by the generic Kidscreen instrument in three
groups of 12-year-olds with: i) undetected celiac disease at
the data collection, who thereafter received the diagnosis
through screening, ii) clinically diagnosed celiac disease,
and iii) children without celiac disease.Methods
Design, procedure and study population
This study emanated from a school-based, cross-sectional,
screening study entitled ETICS (Exploring the Iceberg of
Celiacs in Sweden), which has previously been described
in detail elsewhere [16,32,33]. In brief, the study invited all
children in grade six (n = 18325; age ~12 years) attending
schools in and around the five major Swedish cities Lund,
Växjö, Norrköping, Norrtälje and Umeå during two one-
year periods starting in September 2005 and 2009, re-
spectively. At enrollment, the parents reported whether
their child had celiac disease diagnosed through routine
clinical care prior to the study. All children were invited
to provide a blood sample and alongside to fill in a ques-
tionnaire. Data collection was performed in the schools by
research nurses with assistance from school health nurses
and teachers [16,29]. Afterwards, blood samples were ana-
lyzed for serological markers; anti-tissue-transglutaminase
antibodies of IgA-type (tTG) for all children and for some
also anti-endomysial antibodies IgA (EMA), or in case of
IgA-deficiency serological markers of IgG type. Children
with elevated markers (tTG >4 U/mL, or tTG 2–4 U/mL
combined with EMA ≥1:5), but no previous diagnosis of
celiac disease, were recommended a small intestinal bi-
opsy at a close-by pediatric clinic [16,32]. Criteria for
diagnosis were marked enteropathy (Marsh III), or the
combination of milder enteropathy (Marsh I-II), HLA-
DQ2 and/or DQ8 haplotype (genetic predisposition),
symptoms and/or signs compatible with celiac disease,
and clinical response to a gluten-free diet. Parental re-
port of diagnosed celiac disease was confirmed through
medical records and/or the National Swedish Childhood
Celiac Disease Register following the same criteria.
The child’s celiac disease status at data collection was
classified as ‘undetected celiac disease’ if the analyses
showed a biopsy fulfilling the celiac disease criteria, i.e.
the child received the diagnosis through the screening.
To be classified as having ‘diagnosed celiac disease’ the
parental report was confirmed with a diagnosis fulfilling
also our criteria. Children with normal serological
markers were classified as ‘without celiac disease’. In
case of elevated serological markers in the screening
but without biopsy-verified diagnosis (Marsh 0, Marsh
I-II without other requirements, or small intestinal bi-
opsy not performed) children were classified as having
‘potential celiac disease’.
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formed consent to participate, and 12 419 (68%) children
provided both blood samples and questionnaire data and
were included in the current study (Figure 1). The study




HRQoL was assessed by the generic self-report version
of the 52 item Kidscreen instrument [20-22]. This instru-
ment measures overall HRQoL along with 10 HRQoL
subdomains capturing: physical well-being, psychological
well-being, moods and emotions, self-perception, auton-
omy, parent relation and home life, financial resources, so-
cial support and peers, school environment, and social
acceptance (bullying). Items utilize a 5-point response
scale and a four week recall time. As recommended, scores
were reversed and linearly transformed into a 0–100 scale
with higher values indicating better HRQoL, and mean
scores were estimated for all domains, given no more
than one item were missing within the domain [20]. An
exception was domains with only three items, i.e. finan-
cial resources and social acceptance, for which no miss-
ing were allowed. In the current study, items with
multiple responses (n = 1053, 0.16%) were recoded as




















Figure 1 Participants in the study. The number of participating
children with both a blood sample available for analyses of celiac
disease (CD) serological markers, and a returned questionnaire (shaded
grey). Included children are further divided into groups according to
their CD status; undetected CD later receiving the diagnosis through
the screening, potential CD i.e. elevated serological markers in the
screening but without biopsy-verified diagnosis, diagnosed CD prior to
the study treated with gluten-free diet, and children without CD. Three
groups are included in the analyses (bold line).multiple responses were handled as missing. Overall
HRQoL was only estimated for children with available
scores within all 10 subdomains. Domain scores were
described as low if below the lowest quartile (≤25 per-
centile among the children without celiac disease) for
the specific domain. The Kidscreen instrument has
demonstrated acceptable levels of reliability and validity
among children and adolescents in several countries includ-
ing Sweden [21,22]. In this study population, the internal
consistency was satisfactory (Cronbach’s alpha >0.7 for
all domains) both among children with celiac disease
and those without.
Celiac disease associated gastrointestinal symptoms
were measured by additional questions capturing eight
symptoms: nausea, stomach ache, upset stomach, ab-
dominal gas, bloating, hard stools, loose stools and poor
appetite [34]. All responses were given on a 5-point scale
ranging from never to always over the past six months.
Presence of gastrointestinal symptom(s) was defined as
having one or more symptom often or always.
Blood samples for estimation of adherence
For children with diagnosed celiac disease blood samples
were analyzed for serological markers as estimation of
adherence with the recommended treatment (gluten-free
diet). The serological marker tTG were determined by
enzyme-linked immunosorbent assay in accordance with
manufacturer’s instructions (Celikey, Phadia GmbH,
Freiburg, Germany) [16]. In these children, tTG >5 U/mL
was interpreted as non-adherence.
Statistical analyses
Microsoft Access 2010 (Microsoft, Redmond, WA)
was used for handling the ETICS database and PASW
Statistics versions 20 (SPSS Inc, Chicago, IL) to perform
statistical analyses. Descriptive information was given as
proportions and mean values with standard deviations
(±SD) or total range. Internal non-response for each
subdomain were excluded, resulting in different number
of children in each respective analyses (undetected celiac
disease n = 227-237, diagnosed celiac disease n = 87-90,
and children without celiac disease n = 11 517–11 963).
Differences of HRQoL domain scores between children
without celiac disease and undetected or diagnosed ce-
liac disease, respectively, were tested by the Mann–
Whitney U-test. This test was performed in the whole
group and as well as after stratifications. Comparisons
between proportions were performed by Chi-square test.
Univariate and multivariate logistic regression models
tested the odds of a low HRQoL score among children
with undetected or diagnosed celiac disease compared
to children without celiac disease. Multivariate models
were adjusted for sex, study year (2005 or 2009), geo-
graphical area of residence (five areas), and the presence
Table 1 Characteristics of the participating children







N = 238 N = 90 N = 12 037
Sex
Girls 58 68 49
Boys 42 32 51
Year
2005 63 66 57
2009 37 34 43
Geographical
area of residence
Lund 42 48 44
Växjö 20 14 14
Norrköping 11 17 12
Norrtälje 13 4 11
Umeå 14 17 18
Gastrointestinal
symptoms
No 79 78 78
Yes 21 22 22
1At the data collection CD was undetected, later diagnosed through screening.
2CD diagnosed through routine clinical care prior to the study.
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nificance was defined as a two-tailed P < 0.05 correspond-
ing to an odds ratio (OR) with a 95% confidence interval
(CI) not including 1. For significant findings, the size of
the difference was estimated using Cohen’s d, defined as
the difference in mean between the groups divided by the
pooled SD, and interpreted as small if below 0.20, moder-
ate around 0.50 and large above 0.80 [35].
Results
Characteristics of the participants
Of the 12 419 participating children with both blood
samples and questionnaire data, 292 children without di-
agnosed celiac disease presented elevated serological
markers. Of these 13 declined further investigation with
small intestinal biopsy and 41 had a normal biopsy, leav-
ing 238 children (137 girls) with undetected celiac dis-
ease at data collection (Figure 1). The 54 children with
potential celiac disease were not further analysed in this
sub-study. Among the remaining, 90 children (61 girls)
were classified as having diagnosed celiac disease and
they had been all recommended a gluten-free diet. Mean
age (±SD) at diagnosis was 4.7 ± 4.0 years and the major-
ity (n = 83, 92%) had normal tTG at data collection.
Seven children revealed elevated tTG, indicating non-
adherence with the gluten-free diet (range 9.0-30 U/ml).
They were not handled separately, since they were few
and there was no correlation between tTG and HRQoL
(r2 = 0.24).
In Table 1 the characteristics of the participants stratified
by celiac disease status is summarized. In 2005, a larger
number of children were invited than in 2009 due to
declining birth rates in Sweden. The largest study site
was Lund [32]. Children with undetected celiac disease
reported gastrointestinal symptoms equally commonly
as the children without celiac disease (21.1% vs. 21.8%,
P = 0.80). Of the children with diagnosed celiac disease
22.2% reported symptom (Table 1).
HRQoL in children with celiac disease, undetected or
diagnosed
In general, the children reported relatively high HRQoL
(mean ± SD: 82.5 ± 11.3), with functioning and wellbeing
in the 10 HRQoL subdomains ranging from a mean
score of 76.4 ± 17.1 (school environment) to 92.0 ± 14.7
(social acceptance).
Children with undetected celiac disease reported com-
parable overall HRQoL as their peers without celiac dis-
ease (mean ± SD: 83.0 ± 11.0 vs. 82.5 ± 11.3, P = 0.51), and
there was no difference between children with undetected
and diagnosed celiac disease either (mean ± SD: 83.0 ± 11.0
vs. 82.2 ± 12.2, P = 0.28). These findings were replicated in
all HRQoL subdomains (Figure 2). Details are found in
Additional file 1: Table S1. Moreover, having undetectedceliac disease did not increase the odds of low overall
functioning and wellbeing, independent of sex, area of
residence, study year and occurrence of gastrointestinal
symptoms (adjusted OR 0.77, 95% CI 0.54-1.10). Similarly,
we found no increased unadjusted or adjusted odds in any
separate HRQoL subdomain (Table 2).
Children with diagnosed celiac disease also reported
similar overall HRQoL as children without celiac disease
(mean ± SD: 82.2 ± 12.2 vs. 82.5 ± 11.3, P = 0.29). Again,
the findings were replicated in all 10 HRQoL subdo-
mains studied (Figure 2). Diagnosed celiac disease was
not associated with low overall functioning and well-
being. Adjusting for sex, area of residence, study year
and gastrointestinal symptoms did not affect the finding
(adjusted OR 1.11, 95% CI 0.67-1.85) and similar results
were seen for all 10 HRQoL subdomains (Table 2).
Considering the HRQoL stratified by sex showed no
differences between children with and without celiac dis-
ease (Figure 3), although girls reported lower HRQoL
than boys, except for the domains of social support and
peers, and school environment which had the opposed
relationship. Children reporting gastrointestinal symp-
toms also reported lower HRQoL than those without
symptoms. Stratified analyses showed no HRQoL differ-
ence between children with and without celiac disease
independent of the occurrence gastrointestinal symp-














10 subdomains of HRQoL
HRQoL in children with or without CD
0
Figure 2 HRQoL in children with and without celiac disease.
Health-related quality of life (HRQoL) profiles assessed with the
Kidscreen-52 subdomains for the three groups of children; with
undetected or diagnosed celiac disease (CD), and without CD
(non-CD). We observed no statistically significant difference in
any subdomain.
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in 2005 compared to 2009, however, the effect size was
neglectable (Cohen’s d <0.1) (Additional file 2: Table S2)
and the two groups were handled as one.
Discussion
In this large population based study in Sweden, children
with undetected celiac disease reported similar HRQoL
as children with diagnosed celiac disease. These children
also reported HRQoL comparable to Swedish children
without celiac disease. Accordingly, children with un-
detected or diagnosed celiac disease were not at in-
creased odds for having low HRQoL. To the best of our
knowledge, this is the first large population based study
capturing the HRQoL of children with both undetected
and diagnosed celiac disease by use of a comprehensive
standardized HRQoL measure.
A previous population based study from our group,
found no HRQoL difference between 153 school aged
children with undetected celiac disease and children
without celiac disease, when investigating self-reported
HRQoL by the shorter six item EQ-5D-Y HRQoL instru-
ment [29]. In the current study we confirmed these re-
sults in an extended study group (238 12-year old
children with undetected celiac disease) and by use of a
more comprehensive assessment of HRQoL (full-form52 item Kidscreen instrument). These findings thus sug-
gest that HRQoL is not impaired in school aged children
with undetected celiac disease.
One study in younger children is however partly con-
tradictive. This study found lower parent-reported
HRQoL in children diagnosed through screening at age
2–4 years, but only among the children with gastrointes-
tinal symptoms; children without symptoms had similar
HRQoL as a population based reference group [36]. In
our study, stratifying for gastrointestinal symptoms did
not affect the results. The issue of gastrointestinal symp-
toms in children with celiac disease is however compli-
cated. In a qualitative study from our group it was
shown that school aged children diagnosed with celiac
disease through screening in retrospect realized that they
had experienced a varying degree of symptoms associ-
ated with the undetected disease, which they were not
aware of prior to treatment [13]. Similarly, among chil-
dren who were diagnosed with celiac disease through
screening in at-risk groups, 50% of those with no symp-
toms at diagnosis reported alleviation of symptoms after
one year of treatment [28], further indicating that un-
awareness of celiac disease related symptoms prior to
treatment is common among children. This adaption to
symptoms related to celiac disease in childhood may
partly explain the lack of HRQoL impairment in children
with undetected celiac disease when they report prior to
knowledge of the disease.
Our findings of an unimpaired self-reported HRQoL
in children with undetected celiac disease contributes to
an understanding of why most celiac disease cases are
not identified in clinical practice. Despite moderate to
severe enteropathy [16,32], they are not presenting an af-
fected overall HRQoL, and children with a low HRQoL
do not have higher odds of undetected celiac disease
than other children. Thus, mass screening using sero-
logical markers might be necessary to identify all cases
of celiac disease. However, the issue of mass screening is
still controversial and more research is needed before it
can be determined whether it is an appropriate public
health intervention or not [3,17].
In our study also children with diagnosed celiac dis-
ease reported HRQoL corresponding to that of children
without celiac disease. This finding has been seen also in
other studies [29,36,37], although previous findings are
not conclusive. Inconclusive findings could originate
from different methods for assessing HRQoL, especially
when taking different aspects of HRQoL into account.
Domains more linked to feeding and socialization have
been shown to be more impaired due to the gluten-free
diet [30,31,38]. In line with these findings we saw the
highest odds for low HRQoL among children with di-
agnosed celiac disease in the subdomain school envir-
onment, although the difference was not statistically
Table 2 Odds of low health-related quality of life (HRQoL)
in children with undetected and diagnosed celiac disease
(CD) compared with children without CD
HRQoL1 Low HRQoL Crude Adjusted
n (%)2 OR (95% CI)3 OR (95% CI)4
Physical well-being
Without CD5 3491 (29.6) 1 1
Undetected CD6 66 (28.3) 0.94 (0.71-1.26) 0.93 (0.69-1.27)
Diagnosed CD7 30 (33.7) 1.21 (0.78-1.88) 1.29 (0.81-2.06)
Psychological
well-being
Without CD 3501 (29.7) 1 1
Undetected CD 69 (29.6) 0.99 (0.75-1.32) 0.98 (0.73-1.34)
Diagnosed CD 28 (31.5) 1.09 (0.69-1.70) 1.14 (0.71-1.82)
Moods and
emotions
Without CD 3169 (26.8) 1 1
Undetected CD 58 (25.0) 0.91 (0.67-1.23) 0.85 (0.62-1.18)
Diagnosed CD 24 (26.7) 0.99 (0.62-1.59) 1.0 (0.61-1.65)
Self-perception
Without CD 3372 (28.2) 1 1
Undetected CD 60 (25.5) 0.87 (0.65-1.17) 0.79 (0.58-1.09)
Diagnosed CD 32 (35.6) 1.41 (0.91-2.17) 1.15 (0.72-1.86)
Autonomy
Without CD 3015 (25.2) 1 1
Undetected CD 49 (20.7) 0.77 (0.56-1.06) 0.74 (0.53-1.03)
Diagnosed CD 22 (24.7) 0.97 (0.60-1.58) 0.96 (0.57-1.60)
Parent relation
and home life
Without CD 2469 (20.8) 1 1
Undetected CD 45 (19.2) 0.91 (0.65-1.26) 0.85 (0.60-1.21)
Diagnosed CD 16 (18.0) 0.83 (0.49-1.44) 0.92 (0.52-1.60)
Financial resources
Without CD 4048 (34.8) 1 1
Undetected CD 75 (33.0) 0.92 (0.70-1.22) 0.84 (0.63-1.13)
Diagnosed CD 31 (35.2) 1.02 (0.66-1.58) 0.94 (0.59-1.51)
Social support
and peers
Without CD 2403 (20.2) 1 1
Undetected CD 41 (17.4) 0.83 (0.59-1.17) 0.92 (0.65-1.30)
Diagnosed CD 19 (21.1) 1.06 (0.64-1.76) 1.30 (0.77-2.19)
School environment
Without CD 2527 (21.9) 1 1
Undetected CD 44 (19.0) 0.84 (0.61-1.17) 0.84 (0.59-1.20)
Diagnosed CD 24 (27.6) 1.36 (0.85-2.17) 1.30 (0.77-2.18)
Table 2 Odds of low health-related quality of life (HRQoL)
in children with undetected and diagnosed celiac disease
(CD) compared with children without CD (Continued)
Social acceptance (bullying)
Without CD 2499 (21.7) 1 1
Undetected CD 52 (22.6) 1.05 (0.77-1.44) 1.06 (0.76-1.47)
Diagnosed CD 14 (16.1) 0.69 (0.39-1.23) 0.72 (0.39-1.31)
1HRQoL was assessed using the Kidscreen-52 instrument.
2Low HRQoL was defined as the children reporting a score in the lowest
quartile. Number and proportion of children reporting low HRQoL, excluding
internal non-response for each respective subdomain.
3Univariate logistic regression giving the odds ratio (OR) with 95% confidence
interval (CI).
4Multivariate logistic regression model including sex, phase of the study,
geographical area, and presence of gastrointestinal symptoms.
5Children with normal serological markers (N = 12 037).
6At the collection of the HRQoL data CD was undetected (N = 238), later
diagnosed through screening.
7CD diagnosed through routine clinical care prior to the study (N = 90).
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strument focuses in detail on aspects affected by the
gluten-free diet and could therefore be more sensitive
than a generic instrument [23,38]. Thus, we cannot ex-
clude that our findings could, at least partly, be explained
by a failure of the generic instrument Kidscreen to fully
capture if diagnosed celiac disease affects HRQoL.
It has been shown that adherence with the gluten-free
diet is important for obtaining similar HRQoL among
children with celiac disease as their peers [39]. However,
the burden of following a strict gluten-free diet has been
associated with reduced HRQoL [40]. In our study, adher-
ence with the gluten-free diet was high (92%) in compari-
son with other studies [14,31,41]. However, occasional
gluten intake might not be captured by elevated tTG
resulting in overestimation of the adherence. We were
also limited by the cross-sectional study design where in-
ference whether non-adherence affected HRQoL, or if
children with low HRQoL due to other reasons did not
manage to adhere to the gluten-free diet, could not be
made. Therefore, we did not further investigate the influ-
ence of adherence on HRQoL in our study. Larger longi-
tudinal studies investigating the influence of treatment
adherence on HRQoL, and visa verse, are warranted.
A strength of our study was that it was based on an
actual population-based screening study. Thus, the chil-
dren with undetected celiac disease emanated from the
general population, and in contrast to several other stud-
ies, we were able to assess the HRQoL prior to the diagno-
sis of screening-detected celiac disease [23,28]. Moreover,
the children with diagnosed celiac disease were also iden-
tified from the general population, compared to the more
common recruitment through patient societies [23]. As
there may be a selection in who joins a patient society, the
current strategy is likely to give a more accurate descrip-
tion of HRQoL in children with diagnosed celiac disease.
The population-based strategy, however, also constituted a




Figure 3 HRQoL in children with and without celiac disease, stratified by sex and gastrointestinal symptoms. Health-related quality of life
(HRQoL) profiles by Kidscreen-52 subdomains for the three groups of children; with undetected or diagnosed celiac disease (CD), and without CD
(non-CD) stratified by sex and presence of gastrointestinal symptoms (yes or no). Overall, girls and children with gastrointestinal symptoms
reported lower HRQoL but we observed no difference between the three groups in any subdomain in any strata.
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ticipants) the number of children with celiac disease were
limited and we cannot exclude that lack of power affected
our findings, especially after stratifications. The partici-
pants comprised 69% of all invited children in sixth grade.
Their HRQoL were comparable to the that found by the
Swedish National Institute of Public Health when they
performed a countrywide, all-encompassing survey using
the same HRQoL instrument, during the same time
period, and in the same age group [42]. This suggests that
our HRQoL results are representative for 12-year-old chil-
dren in Sweden, and due to the homogeneity of the Swed-
ish society, the association between HRQoL and celiac
disease likely is the same across the country. The lack of
adjustment for socioeconomic status may, however,
constitute a potential limitation. Socioeconomic status
is negatively associated with HRQoL [43], and might be
associated with celiac disease, thereby constituting a po-
tential confounder. However, the relationship between so-
cioeconomic status and celiac disease has contradictoryfindings also from Sweden [44-46], with the largest
study rejecting an association [47]. To the best of our
knowledge, the only previous study which has tested
the potential influence of socioeconomic status on
HRQoL in celiac disease did not find an association be-
tween the two [48].
Conclusion
Children with undetected and thereby untreated celiac
disease reported comparable HRQoL as their peers when
reporting prior to receiving the celiac disease diagnosis
through screening. They also reported similar HRQoL as
children with diagnosed celiac disease. Thus, children
with diagnosed and treated celiac disease may be able to
attain the same HRQoL as their peers without the dis-
ease. HRQoL encompasses several areas of functioning
and wellbeing, and the current study suggests that chil-
dren with celiac disease, both undetected and diagnosed,
perceive unimpaired functioning and wellbeing within
all such areas of HRQoL.
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